<p><!--
QBlastInfoBegin
	Status=READY
QBlastInfoEnd
--><p>
<PRE>
BLASTP 2.6.1+
Reference: Stephen F. Altschul, Thomas L. Madden, Alejandro
A. Schaffer, Jinghui Zhang, Zheng Zhang, Webb Miller, and
David J. Lipman (1997), "Gapped BLAST and PSI-BLAST: a new
generation of protein database search programs", Nucleic
Acids Res. 25:3389-3402.


Reference for compositional score matrix adjustment: Stephen
F. Altschul, John C. Wootton, E. Michael Gertz, Richa
Agarwala, Aleksandr Morgulis, Alejandro A. Schaffer, and
Yi-Kuo Yu (2005) "Protein database searches using
compositionally adjusted substitution matrices", FEBS J.
272:5101-5109.


RID: SHK2XT3C015


Database: PDB protein database
           92,826 sequences; 23,299,537 total letters
Query= sp|P11802|CDK4_HUMAN Cyclin-dependent kinase 4 OS=Homo sapiens GN=CDK4
PE=1 SV=2

Length=303


                                                                   Score     E
Sequences producing significant alignments:                       (Bits)  Value

3G33_A  Chain A, Crystal Structure Of Cdk4CYCLIN D3                623     0.0   
5FWK_K  Chain K, Atomic Cryoem Structure Of Hsp90-cdc37-cdk4 C...  623     0.0   
2W99_B  Chain B, Crystal Structure Of Cdk4 In Complex With A D...  604     0.0   
2W96_B  Chain B, Crystal Structure Of Cdk4 In Complex With A D...  603     0.0   
2W9F_B  Chain B, Crystal Structure Of Cdk4 In Complex With A D...  603     0.0   
1JOW_B  Chain B, Crystal Structure Of A Complex Of Human Cdk6 ...  430     6e-153
1BI8_A  Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhib...  430     1e-152
3NUP_A  Chain A, Cdk6 (Monomeric) In Complex With Inhibitor        429     2e-152
1GII_A  Chain A, Human Cyclin Dependent Kinase 2 Complexed Wit...  253     2e-83 
2IW8_A  Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin...  253     5e-83 
5K4J_A  Chain A, Crystal Structure Of Cdk2 In Complex With Com...  248     2e-81 
1OIT_A  Chain A, Imidazopyridines: A Potent And Selective Clas...  248     3e-81 
1GZ8_A  Chain A, Human Cyclin Dependent Kinase 2 Complexed Wit...  248     4e-81 
3EZR_A  Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its...  248     5e-81 
1PF8_A  Chain A, Crystal Structure Of Human Cyclin-dependent K...  247     5e-81 
1FIN_A  Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex        247     5e-81 
2W17_A  Chain A, Cdk2 In Complex With The Imidazole Pyrimidine...  247     5e-81 
3PJ8_A  Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[...  247     6e-81 
5UQ1_A  Chain A, Crystal Structure Of Human Cdk2-spy1 Complex      247     7e-81 
2IW6_A  Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin...  247     7e-81 
4ERW_A  Chain A, Cdk2 In Complex With Staurosporine                247     8e-81 
3PXF_A  Chain A, Cdk2 In Complex With Two Molecules Of 8-Anili...  247     1e-80 
4EOO_A  Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyc...  246     1e-80 
4EOI_A  Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Hum...  246     1e-80 
4EOP_A  Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyc...  246     2e-80 
1VYW_A  Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137         246     2e-80 
2JGZ_A  Chain A, Crystal Structure Of Phospho-Cdk2 In Complex ...  246     2e-80 
1QMZ_A  Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Pepti...  245     3e-80 
1E9H_A  Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 C...  245     3e-80 
3BHT_A  Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN...  245     3e-80 
1W98_A  Chain A, The Structural Basis Of Cdk2 Activation By Cy...  245     3e-80 
4I3Z_A  Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 ...  245     4e-80 
1H01_A  Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis...  245     4e-80 
1OIR_A  Chain A, Imidazopyridines: A Potent And Selective Clas...  245     4e-80 
1JST_A  Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Boun...  245     4e-80 
3QHR_A  Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State ...  245     4e-80 
4BCQ_A  Chain A, Structure Of Cdk2 In Complex With Cyclin A An...  245     4e-80 
4EOQ_A  Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin...  245     4e-80 
4EOS_A  Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin...  245     4e-80 
1OGU_A  Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin...  245     4e-80 
1H1P_A  Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN ...  245     5e-80 
4EON_A  Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e...  245     5e-80 
4CFU_A  Chain A, Structure-based Design Of C8-substituted O6- ...  245     5e-80 
4EOM_A  Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e...  244     7e-80 
4EOK_A  Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d ...  243     2e-79 
4EOJ_A  Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d ...  243     3e-79 
2CJM_A  Chain A, Mechanism Of Cdk Inhibition By Active Site Ph...  242     6e-79 
4YC6_A  Chain A, Cdk1/cks1                                         236     1e-76 
4Y72_A  Chain A, Human Cdk1/cyclinb1/cks2 With Inhibitor           236     2e-76 
1V0B_A  Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5    234     4e-76 
1V0O_A  Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-...  234     4e-76 
1OB3_A  Chain A, Structure Of P. Falciparum Pfpk5                  234     4e-76 
4AU8_A  Chain A, Crystal Structure Of Compound 4a In Complex W...  232     5e-75 
3NIZ_A  Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinas...  233     5e-75 
2QKR_A  Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinas...  233     5e-75 
1H4L_A  Chain A, Structure And Regulation Of The Cdk5-P25(Nck5...  229     7e-74 
1UNG_A  Chain A, Structural Mechanism For The Inhibition Of Cd...  227     3e-73 
2PK9_A  Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Compl...  218     3e-69 
3MTL_A  Chain A, Crystal Structure Of The Pctaire1 Kinase In C...  206     2e-64 
3GBZ_A  Chain A, Structure Of The Cmgc Cdk Kinase From Giardia...  199     6e-62 
1UA2_A  Chain A, Crystal Structure Of Human Cdk7                   191     2e-58 
4UN0_C  Chain C, Crystal Structure Of The Human Cdk12-cyclink ...  187     4e-57 
4CXA_A  Chain A, Crystal Structure Of The Human Cdk12-cyclin K...  187     5e-57 
5EFQ_A  Chain A, Crystal Structure Of Human Cdk13/cyclin K In ...  187     8e-57 
4NST_A  Chain A, Crystal Structure Of Human Cdk12/cyclin K In ...  187     1e-56 
4BCF_A  Chain A, Structure Of Cdk9 In Complex With Cyclin T An...  178     1e-53 
5L1Z_A  Chain A, Tar Complex With Hiv-1 Tat-aff4-p-tefb            177     2e-53 
4OR5_A  Chain A, Crystal Structure Of Hiv-1 Tat Complexed With...  177     2e-53 
4IMY_A  Chain A, The Aff4 Scaffold Binds Human P-tefb Adjacent...  177     2e-53 
3BLH_A  Chain A, Crystal Structure Of Human Cdk9CYCLINT1           177     3e-53 
3MI9_A  Chain A, Crystal Structure Of Hiv-1 Tat Complexed With...  177     6e-53 
4EC8_A  Chain A, Structure Of Full Length Cdk9 In Complex With...  177     9e-53 
5CI6_A  Chain A, Crystal Structure Of Arabidopsis Thaliana Mpk6    176     4e-52 
4S2Z_A  Chain A, Erk2 Intrinsically Active Mutant R65s             175     6e-52 
4XOY_A  Chain A, Crystal Structure Of Erk2 In Complex With An ...  174     7e-52 
4XNE_A  Chain A, Crystal Structure Of Erk2 In Complex With An ...  174     1e-51 
4XRL_A  Chain A, Crystal Structure At Room Temperature Of Erk2...  173     1e-51 
4N0S_A  Chain A, Complex Of Erk2 With Caffeic Acid                 174     2e-51 
4XP2_A  Chain A, Crystal Structure Of Erk2 In Complex With An ...  173     2e-51 
4FV7_A  Chain A, Crystal Structure Of The Erk2 Complexed With E94  173     2e-51 
4XJ0_A  Chain A, Crystal Structure Of Erk2 In Complex With An ...  173     2e-51 
5LCK_A  Chain A, A Clickable Covalent Erk 1/2 Inhibitor            173     2e-51 
3SA0_A  Chain A, Complex Of Erk2 With Norathyriol                  173     2e-51 
4H3Q_A  Chain A, Crystal Structure Of Human Erk2 Complexed Wit...  173     3e-51 
5K4I_A  Chain A, Crystal Structure Of Erk2 In Complex With Com...  172     3e-51 
4QTA_A  Chain A, Structure Of Human Erk2 In Complex With Sch77...  173     3e-51 
4ZZM_A  Chain A, Human Erk2 In Complex With An Irreversible In...  172     3e-51 
2Y9Q_A  Chain A, Crystal Structure Of Human Erk2 Complexed Wit...  173     3e-51 
4GSB_A  Chain A, Monoclinic Crystal Form Of The Apo-Erk2           173     3e-51 
3O71_A  Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX      172     3e-51 
4XOZ_A  Chain A, Crystal Structure Of Erk2 In Complex With An ...  172     3e-51 
5BUE_A  Chain A, Erk2 Complexed With N-benzylpyridone Tetrahyd...  172     4e-51 
4FUX_A  Chain A, Crystal Structure Of The Erk2 Complexed With E75  172     4e-51 
4QP1_A  Chain A, Crystal Structure Of Erk2 In Complex With N-c...  173     4e-51 
3C9W_A  Chain A, Crystal Structure Of Erk-2 With Hypothemycin ...  172     4e-51 
4I5H_A  Chain A, Crystal Structure Of A Double Mutant Rat Erk2...  172     4e-51 
4FV6_A  Chain A, Crystal Structure Of The Erk2 Complexed With E57  172     4e-51 
3R63_A  Chain A, Structure Of Erk2 (Spe) Mutant (S246e)            172     4e-51 
2FYS_B  Chain B, Crystal Structure Of Erk2 Complex With Kim Pe...  172     5e-51 
3QYW_A  Chain A, Crystal Structure Of Erk2 In Complex With An ...  172     5e-51 

ALIGNMENTS
>3G33_A Chain A, Crystal Structure Of Cdk4CYCLIN D3
 3G33_C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length=308

 Score = 623 bits (1607),  Expect = 0.0, Method: Compositional matrix adjust.
 Identities = 303/303 (100%), Positives = 303/303 (100%), Gaps = 0/303 (0%)

Query  1    MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL  60
            MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL
Sbjct  6    MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL  65

Query  61   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  120
            RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL
Sbjct  66   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  125

Query  121  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY  180
            MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY
Sbjct  126  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY  185

Query  181  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  240
            RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR
Sbjct  186  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  245

Query  241  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  300
            DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG
Sbjct  246  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305

Query  301  NPE  303
            NPE
Sbjct  306  NPE  308


>5FWK_K Chain K, Atomic Cryoem Structure Of Hsp90-cdc37-cdk4 Complex
 5FWL_K Chain K, Atomic Cryoem Structure Of Hsp90-cdc37-cdk4 Complex
 5FWM_K Chain K, Atomic Cryoem Structure Of Hsp90-cdc37-cdk4 Complex
 5FWP_K Chain K, Atomic Cryoem Structure Of Hsp90-cdc37-cdk4 Complex
Length=310

 Score = 623 bits (1607),  Expect = 0.0, Method: Compositional matrix adjust.
 Identities = 303/303 (100%), Positives = 303/303 (100%), Gaps = 0/303 (0%)

Query  1    MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL  60
            MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL
Sbjct  8    MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL  67

Query  61   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  120
            RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL
Sbjct  68   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  127

Query  121  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY  180
            MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY
Sbjct  128  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY  187

Query  181  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  240
            RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR
Sbjct  188  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  247

Query  241  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  300
            DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG
Sbjct  248  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  307

Query  301  NPE  303
            NPE
Sbjct  308  NPE  310


>2W99_B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
 2W9Z_B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length=306

 Score = 604 bits (1558),  Expect = 0.0, Method: Compositional matrix adjust.
 Identities = 297/303 (98%), Positives = 297/303 (98%), Gaps = 3/303 (1%)

Query  1    MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL  60
            MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG  G   LPISTVREVALL
Sbjct  1    MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEG---LPISTVREVALL  57

Query  61   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  120
            RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL
Sbjct  58   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  117

Query  121  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY  180
            MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL PVVVTLWY
Sbjct  118  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWY  177

Query  181  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  240
            RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR
Sbjct  178  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  237

Query  241  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  300
            DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG
Sbjct  238  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  297

Query  301  NPE  303
            NPE
Sbjct  298  NPE  300


>2W96_B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length=306

 Score = 603 bits (1556),  Expect = 0.0, Method: Compositional matrix adjust.
 Identities = 297/303 (98%), Positives = 297/303 (98%), Gaps = 3/303 (1%)

Query  1    MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL  60
            MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG  G   LPISTVREVALL
Sbjct  1    MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEG---LPISTVREVALL  57

Query  61   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  120
            RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL
Sbjct  58   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  117

Query  121  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY  180
            MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL PVVVTLWY
Sbjct  118  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWY  177

Query  181  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  240
            RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR
Sbjct  178  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  237

Query  241  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  300
            DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG
Sbjct  238  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  297

Query  301  NPE  303
            NPE
Sbjct  298  NPE  300


>2W9F_B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length=306

 Score = 603 bits (1555),  Expect = 0.0, Method: Compositional matrix adjust.
 Identities = 297/303 (98%), Positives = 297/303 (98%), Gaps = 3/303 (1%)

Query  1    MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL  60
            MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG  G   LPISTVREVALL
Sbjct  1    MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEG---LPISTVREVALL  57

Query  61   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  120
            RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL
Sbjct  58   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  117

Query  121  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY  180
            MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL PVVVTLWY
Sbjct  118  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWY  177

Query  181  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  240
            RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR
Sbjct  178  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  237

Query  241  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  300
            DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG
Sbjct  238  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  297

Query  301  NPE  303
            NPE
Sbjct  298  NPE  300


>1JOW_B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral 
Cyclin
 1XO2_B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 
6 Complex With A Flavonol Inhibitor, Fisetin
 2EUF_B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With 
The Inhibitor Pd0332991
 2F2C_B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor 
Aminopurvalanol
Length=308

 Score = 430 bits (1106),  Expect = 6e-153, Method: Compositional matrix adjust.
 Identities = 211/303 (70%), Positives = 243/303 (80%), Gaps = 4/303 (1%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL  60
            A  +YE VAEIG GAYG V+KARD  + G FVALK VRV  G  G   +P+ST+REVA+L
Sbjct  9    ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVL  65

Query  61   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  120
            R LE FEHPNVVRL DVC  SRTDRE K+TLVFEHVDQDL TYLDK P PG+P ETIKD+
Sbjct  66   RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM  125

Query  121  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY  180
            M Q LRGLDFLH++ +VHRDLKP+NILVTS G +KLADFGLARIYS+QMALT VVVTLWY
Sbjct  126  MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY  185

Query  181  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  240
            RAPEVLLQS+YATPVD+WSVGCIFAEMFRRKPLF G+S+ DQLGKI D+IGLP E+DWPR
Sbjct  186  RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245

Query  241  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  300
            DV+LPR AF  +  +P++  V +++E G  LLL+ LTFNP KRISA+ AL H Y    E 
Sbjct  246  DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305

Query  301  NPE  303
              E
Sbjct  306  CKE  308


>1BI8_A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From 
The Structures Cdk6-P19ink4d Inhibitor Complex
 1BI8_C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From 
The Structures Cdk6-P19ink4d Inhibitor Complex
 1BI7_A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From 
The Structure Of The Cdk6-P16ink4a Tumor Suppressor Complex
 1BLX_A Chain A, P19ink4dCDK6 COMPLEX
 1G3N_A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
 1G3N_E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
 4TTH_B Chain B, Crystal Structure Of A Cdk6/vcyclin Complex With Inhibitor 
Bound
Length=326

 Score = 430 bits (1106),  Expect = 1e-152, Method: Compositional matrix adjust.
 Identities = 211/303 (70%), Positives = 243/303 (80%), Gaps = 4/303 (1%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL  60
            A  +YE VAEIG GAYG V+KARD  + G FVALK VRV  G  G   +P+ST+REVA+L
Sbjct  9    ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVL  65

Query  61   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  120
            R LE FEHPNVVRL DVC  SRTDRE K+TLVFEHVDQDL TYLDK P PG+P ETIKD+
Sbjct  66   RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM  125

Query  121  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY  180
            M Q LRGLDFLH++ +VHRDLKP+NILVTS G +KLADFGLARIYS+QMALT VVVTLWY
Sbjct  126  MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY  185

Query  181  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  240
            RAPEVLLQS+YATPVD+WSVGCIFAEMFRRKPLF G+S+ DQLGKI D+IGLP E+DWPR
Sbjct  186  RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245

Query  241  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  300
            DV+LPR AF  +  +P++  V +++E G  LLL+ LTFNP KRISA+ AL H Y    E 
Sbjct  246  DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305

Query  301  NPE  303
              E
Sbjct  306  CKE  308


>3NUP_A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
 3NUX_A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
 4AUA_A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent 
Kinase 6 (cdk6)
 4EZ5_A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
 5L2I_A Chain A, The X-ray Co-crystal Structure Of Human Cdk6 And Palbociclib.
 5L2S_A Chain A, The X-ray Co-crystal Structure Of Human Cdk6 And Abemaciclib.
 5L2T_A Chain A, The X-ray Co-crystal Structure Of Human Cdk6 And Ribociclib.
Length=307

 Score = 429 bits (1104),  Expect = 2e-152, Method: Compositional matrix adjust.
 Identities = 209/296 (71%), Positives = 241/296 (81%), Gaps = 4/296 (1%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL  60
            A  +YE VAEIG GAYG V+KARD  + G FVALK VRV  G  G   +P+ST+REVA+L
Sbjct  9    ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVL  65

Query  61   RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL  120
            R LE FEHPNVVRL DVC  SRTDRE K+TLVFEHVDQDL TYLDK P PG+P ETIKD+
Sbjct  66   RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM  125

Query  121  MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY  180
            M Q LRGLDFLH++ +VHRDLKP+NILVTS G +KLADFGLARIYS+QMALT VVVTLWY
Sbjct  126  MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY  185

Query  181  RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  240
            RAPEVLLQS+YATPVD+WSVGCIFAEMFRRKPLF G+S+ DQLGKI D+IGLP E+DWPR
Sbjct  186  RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245

Query  241  DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            DV+LPR AF  +  +P++  V +++E G  LLL+ LTFNP KRISA+ AL H Y  
Sbjct  246  DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ  301


>1GII_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 
Inhibitor
 1GIJ_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 
Inhibitor
 2DS1_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 
Inhibitor
Length=298

 Score = 253 bits (647),  Expect = 2e-83, Method: Compositional matrix adjust.
 Identities = 137/295 (46%), Positives = 191/295 (65%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  59

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFEHV QDL+T++D +   G+P   IK  + Q L
Sbjct  60   --HPNIVKLLDVIHT-----ENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLL  112

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  113  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  172

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  173  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287


>2IW8_A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- 
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
 2IW8_C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- 
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length=302

 Score = 253 bits (645),  Expect = 5e-83, Method: Compositional matrix adjust.
 Identities = 136/299 (45%), Positives = 191/299 (64%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  60

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFEHVDQDL+ ++D +   G+P   IK  +
Sbjct  61   ELN---HPNIVKLLDVIHT-----ENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL  112

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  113  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  172

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  173  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  232

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  291


>5K4J_A Chain A, Crystal Structure Of Cdk2 In Complex With Compound 22
Length=299

 Score = 248 bits (634),  Expect = 2e-81, Method: Compositional matrix adjust.
 Identities = 135/299 (45%), Positives = 190/299 (64%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            A   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  1    AMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  57

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  58   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  109

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWY
Sbjct  110  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY  169

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  170  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  229

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  230  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  288


>1OIT_A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent 
Kinase Inhibitors Identified Through Structure-based 
Hybridisation
Length=299

 Score = 248 bits (633),  Expect = 3e-81, Method: Compositional matrix adjust.
 Identities = 134/295 (45%), Positives = 189/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  60

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  61   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  113

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  114  QGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  173

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  174  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  233

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  234  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  288


>1GZ8_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
2-amino-6-(3'-methyl-2'-oxo)butoxypurine
 2R3Q_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 2R3M_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 2R3I_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 2R3N_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 2R3O_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 2R3P_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 2R3K_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 2R3J_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 2R3L_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 1W8C_A Chain A, Co-crystal Structure Of 6-cyclohexylmethoxy-8-isopropyl-9h-purin-2- 
Ylamine And Monomeric Cdk2
 4NJ3_A Chain A, Modulating The Interaction Between Cdk2 And Cyclin A 
With A Quinoline- Based Inhibitor
Length=299

 Score = 248 bits (633),  Expect = 4e-81, Method: Compositional matrix adjust.
 Identities = 134/295 (45%), Positives = 189/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  60

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  61   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  113

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  114  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  173

Query  185  VLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  174  ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  233

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  234  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  288


>3EZR_A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active 
Site
 3EZV_A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active 
Site
Length=300

 Score = 248 bits (632),  Expect = 5e-81, Method: Compositional matrix adjust.
 Identities = 134/299 (45%), Positives = 190/299 (64%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  58

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  59   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  110

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWY
Sbjct  111  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY  170

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  171  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  230

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  231  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  289


>1PF8_A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 
Complexed With A Nucleoside Inhibitor
Length=298

 Score = 247 bits (631),  Expect = 5e-81, Method: Compositional matrix adjust.
 Identities = 134/295 (45%), Positives = 189/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  59

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  60   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  112

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  113  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  172

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  173  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287


>1FIN_A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 1FIN_C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 1CKP_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
Purvalanol B
 1BUH_A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With 
Cell Cycle-Regulatory Protein Ckshs1
 1DM2_A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The Inhibitor 
Hymenialdisine
 1DI8_A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In 
Complex With 4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
 1F5Q_A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin 
Complexed To Human Cyclin Dependent Kinase 2
 1F5Q_C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin 
Complexed To Human Cyclin Dependent Kinase 2
 1FVT_A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In 
Complex With An Oxindole Inhibitor
 1FVV_A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE 
Inhibitor
 1FVV_C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE 
Inhibitor
 1JSV_A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In 
Complex With 4-[(6-amino-4-pyrimidinyl) Amino]benzenesulfonamide
 1G5S_A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2 
(Cdk2) In Complex With The Inhibitor H717
 1JVP_P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In 
Complex With Pkf049-365
 1GIH_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 
Inhibitor
 1KE5_A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h- 
Indol-3-ylidene)methyl]amino}benzenesulfonamide
 1KE6_A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With N-Methyl-{4- 
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8- 
Ylidene)hydrazino]phenyl}methanesulfonamide
 1KE7_A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2- 
Dioxido-1,3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5- 
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
 1KE8_A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 4-{[(2-Oxo- 
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3- 
Thiazol-2-Yl)benzenesulfonamide
 1KE9_A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4- 
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-2- 
Oxo-2,3-Dihydro-1h-Indole
 1H0V_A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With 
The Inhibitor 2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
 1H0W_A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With 
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
 1P2A_A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With 
A Trisubstituted Naphthostyril Inhibitor
 1OKV_A Chain A, Cyclin A Binding Groove Inhibitor H-arg-arg-leu-ile-phe-nh2
 1OKV_C Chain C, Cyclin A Binding Groove Inhibitor H-arg-arg-leu-ile-phe-nh2
 1OKW_A Chain A, Cyclin A Binding Groove Inhibitor Ac-arg-arg-leu-asn-(m-cl-phe)-nh2
 1OKW_C Chain C, Cyclin A Binding Groove Inhibitor Ac-arg-arg-leu-asn-(m-cl-phe)-nh2
 1OL1_A Chain A, Cyclin A Binding Groove Inhibitor H-cit-cit-leu-ile-(p-f-phe)-nh2
 1OL1_C Chain C, Cyclin A Binding Groove Inhibitor H-cit-cit-leu-ile-(p-f-phe)-nh2
 1OL2_A Chain A, Cyclin A Binding Groove Inhibitor H-arg-arg-leu-asn-(p-f-phe)-nh2
 1OL2_C Chain C, Cyclin A Binding Groove Inhibitor H-arg-arg-leu-asn-(p-f-phe)-nh2
 1PW2_A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
 1PXI_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2- Ylamine
 1PXJ_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
 1PXK_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]- N'-hydroxyiminoformamide
 1PXL_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]- (4-trifluoromethyl-phenyl)-amine
 1R78_A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
 1PXM_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2- Ylamino]-Phenol
 1PXN_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)- Pyrimidin-2-Ylamino]-Phenol
 1PXO_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2- Yl]-(3-Nitro-Phenyl)-Amine
 1PXP_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]- N',N'-Dimethyl-Benzene-1,4-Diamine
 1VYZ_A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
 1PYE_A Chain A, Crystal Structure Of Cdk2 With Inhibitor
 1URC_A Chain A, Cyclin A Binding Groove Inhibitor Ace-arg-lys-leu-phe-gly
 1URC_C Chain C, Cyclin A Binding Groove Inhibitor Ace-arg-lys-leu-phe-gly
 1W0X_C Chain C, Crystal Structure Of Human Cdk2 In Complex With The 
Inhibitor Olomoucine.
 1WCC_A Chain A, Screening For Fragment Binding By X-Ray Crystallography
 1Y8Y_A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Pyrazolo[1, 
5-A]pyrimidine Inhibitor
 1Y91_A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Pyrazolo[1, 
5-A]pyrimidine Inhibitor
 2BHE_A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With 
The Inhibitor 5-Bromo-Indirubine
 2BHH_A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With 
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
 2B52_A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With 
Dph- 042562
 2B53_A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With 
Din- 234325
 2B54_A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With 
Din- 232305
 2B55_A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With 
Indenopyraxole Din-101312
 2BTR_A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
 2BTS_A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
 2C68_A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The 
Triazolopyrimidine Inhibitor
 2C69_A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The 
Triazolopyrimidine Inhibitor
 2C6I_A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The 
Triazolopyrimidine Inhibitor
 2C6K_A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The 
Triazolopyrimidine Inhibitor
 2C6L_A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The 
Triazolopyrimidine Inhibitor
 2C6M_A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The 
Triazolopyrimidine Inhibitor
 2C6O_A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The 
Triazolopyrimidine Inhibitor
 2EXM_A Chain A, Human Cdk2 In Complex With Isopentenyladenine
 1YKR_A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine 
Inhibitor
 2A0C_X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9- 
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
 2C5N_A Chain A, Differential Binding Of Inhibitors To Active And Inactive 
Cdk2 Provides Insights For Drug Design
 2C5N_C Chain C, Differential Binding Of Inhibitors To Active And Inactive 
Cdk2 Provides Insights For Drug Design
 2C5O_A Chain A, Differential Binding Of Inhibitors To Active And Inactive 
Cdk2 Provides Insights For Drug Design
 2C5O_C Chain C, Differential Binding Of Inhibitors To Active And Inactive 
Cdk2 Provides Insights For Drug Design
 2C5V_A Chain A, Differential Binding Of Inhibitors To Active And Inactive 
Cdk2 Provides Insights For Drug Design
 2C5V_C Chain C, Differential Binding Of Inhibitors To Active And Inactive 
Cdk2 Provides Insights For Drug Design
 2C5X_A Chain A, Differential Binding Of Inhibitors To Active And Inactive 
Cdk2 Provides Insights For Drug Design
 2C5X_C Chain C, Differential Binding Of Inhibitors To Active And Inactive 
Cdk2 Provides Insights For Drug Design
 2C5Y_A Chain A, Differential Binding Of Inhibitors To Active And Inactive 
Cdk2 Provides Insights For Drug Design
 2A4L_A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With Roscovitine
 2FVD_A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine 
Inhibitor
 2I40_A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE 
INHIBITOR
 2I40_C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE 
INHIBITOR
 2CLX_A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar 
Study, Crystal Structure In Complex With Cdk2, Selectivity, 
And Cellular Effects
 2DUV_A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
 2UUE_A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding 
Groove Inhibitors
 2UUE_C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding 
Groove Inhibitors
 2UZN_A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone 
Inhibitor
 2UZO_A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone 
Inhibitor
 2V0D_A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone 
Inhibitor
 1AQ1_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
Staurosporine
 1HCK_A Chain A, Human Cyclin-Dependent Kinase 2
 1HCL_A Chain A, Human Cyclin-Dependent Kinase 2
 2J9M_A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic 
Aminopyrimidine
 2V22_A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding 
Groove Inhibitors
 2V22_C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding 
Groove Inhibitors
 2VTA_A Chain A, Identification Of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- 
Pyrazole-3-carboxamide (at7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment-based X-ray Crystallography 
And Structure Based Drug Design.
 2VTH_A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide 
(At7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment- Based X-Ray 
Crystallography And Structure Based Drug Design
 2VTI_A Chain A, Identification Of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- 
Pyrazole-3-carboxamide (at7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment-based X-ray Crystallography 
And Structure Based Drug Design.
 2VTJ_A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide 
(At7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment- Based X-Ray 
Crystallography And Structure Based Drug Design.
 2VTL_A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide 
(At7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment- Based X-Ray 
Crystallography And Structure Based Drug Design.
 2VTM_A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide 
(At7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment- Based X-Ray 
Crystallography And Structure Based Drug Design.
 2VTN_A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide 
(At7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment- Based X-Ray 
Crystallography And Structure Based Drug Design.
 2VTO_A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide 
(At7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment- Based X-Ray 
Crystallography And Structure Based Drug Design.
 2VTP_A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide 
(At7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment- Based X-Ray 
Crystallography And Structure Based Drug Design.
 2VTQ_A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide 
(At7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment- Based X-Ray 
Crystallography And Structure Based Drug Design.
 2VTR_A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide 
(At7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment- Based X-Ray 
Crystallography And Structure Based Drug Design.
 2VTS_A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide 
(At7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment- Based X-Ray 
Crystallography And Structure Based Drug Design.
 2VTT_A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide 
(At7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment- Based X-Ray 
Crystallography And Structure Based Drug Design.
 2VU3_A Chain A, Identification Of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- 
Pyrazole-3-carboxamide (at7519), A Novel Cyclin 
Dependent Kinase Inhibitor Using Fragment-based X-ray Crystallography 
And Structure Based Drug Design.
 2R64_A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With 
Cdk2
 2W05_A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl Pyrimidine, 
Compound 5b
 3EID_A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 3EID_C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 3EJ1_A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 3EJ1_C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 3EOC_A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 3EOC_C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 2W1H_A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea (At9283), 
A Multi-Targeted Kinase Inhibitor With Potent Aurora 
Kinase Activity
 3F5X_A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound 
At Its Active Site
 3F5X_C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound 
At Its Active Site
 3FZ1_A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound 
To Human Cyclin-Dependent Kinase-2 (Cdk-2)
 2WEV_A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of 
Cdk2, Cyclin A Through Structure Guided Design
 2WEV_C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of 
Cdk2, Cyclin A Through Structure Guided Design
 2WFY_A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of 
Cdk2, Cyclin A Through Structure Guided Design
 2WFY_C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of 
Cdk2, Cyclin A Through Structure Guided Design
 2WHB_A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of 
Cdk2, Cyclin A Through Structure Guided Design
 2WHB_C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of 
Cdk2, Cyclin A Through Structure Guided Design
 2X1N_A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of 
Cdk2, Cyclin A Through Structure Guided Design
 2X1N_C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of 
Cdk2, Cyclin A Through Structure Guided Design
 3LFN_A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole 
Type Inhibitor
 3LFQ_A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole 
Type Inhibitor
 3LFS_A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole 
Type Inhibitor
 2XMY_A Chain A, Discovery And Characterisation Of 2-Anilino-4-(Thiazol-5-Yl) 
Pyrimidine Transcriptional Cdk Inhibitors As Anticancer 
Agents
 2XNB_A Chain A, Discovery And Characterisation Of 2-Anilino-4-(Thiazol-5-Yl) 
Pyrimidine Transcriptional Cdk Inhibitors As Anticancer 
Agents
 3LE6_A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With 
A Pyrazolobenzodiazepine Inhibitor
 3NS9_A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor 
Bs-194
 3S2P_A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine Compound
 3UNJ_A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
 3UNK_A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
 3TI1_A Chain A, Cdk2 In Complex With Sunitinib
 3TIY_A Chain A, Cdk2 In Complex With Nsc 35676
 3TIZ_A Chain A, Cdk2 In Complex With Nsc 111848
 4FX3_A Chain A, Crystal Structure Of The Cdk2/cyclin A Complex With 
Oxindole Inhibitor
 4FX3_C Chain C, Crystal Structure Of The Cdk2/cyclin A Complex With 
Oxindole Inhibitor
 3ULI_A Chain A, Human Cyclin Dependent Kinase 2 (cdk2) Bound To Azabenzimidazole 
Derivative
 4BGH_A Chain A, Crystal Structure Of Cdk2 In Complex With Pan-cdk Inhibitor
 4KD1_A Chain A, Cdk2 In Complex With Dinaciclib
 4LYN_A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 (cdk2-wt) 
Complex With (2s)-n-(5-(((5-tert-butyl-1,3-oxazol-2-yl)methyl)sulfanyl)-1,3- 
Thiazol-2-yl)-2-phenylpropanamide
 3WBL_A Chain A, Crystal Structure Of Cdk2 In Complex With Pyrazolopyrimidine 
Inhibitor
 4D1X_A Chain A, Cdk2 In Complex With Luciferin
 4D1Z_A Chain A, Cdk2 In Complex With A Luciferin Derivate
 5D1J_A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 (cdk2-wt) 
Complex With N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl] 
Methyl]thio]-2-thiazolyl]- 4-piperidinecarboxamide (bms-387032)
 5FP5_A Chain A, Structure Of Cyclin-dependent Kinase 2 With Small-molecule 
Ligand 4-fluorobenzoic Acid (at222) In An Alternate Binding 
Site.
 5FP6_A Chain A, Structure Of Cyclin-dependent Kinase 2 With Small-molecule 
Ligand 3-(4,7-dichloro-1h-indol-3-yl)prop-2-yn-1-ol (at17833) 
In An Alternate Binding Site.
 5AND_A Chain A, Crystal Structure Of Cdk2 In Complex With 2-imidazol-1-yl-1h- 
Benzimidazole Processed With The Crystaldirect Automated 
Mounting And Cryo-cooling Technology
 5ANE_A Chain A, Crystal Structure Of Cdk2 In Complex With 6-methoxy-7h- 
Purine Processed With The Crystaldirect Automated Mounting 
And Cryo-cooling Technology
 5ANG_A Chain A, Crystal Structure Of Cdk2 In Complex With 7-hydroxy-4-(Morpholinomethyl)chromen-2-one 
Processed With The Crystaldirect 
Automated Mounting And Cryo-cooling Technology
 5ANI_A Chain A, Crystal Structure Of Cdk2 In Complex With 6-chloro-7h- 
Purine Processed With The Crystaldirect Automated Mounting 
And Cryo-cooling Technology
 5ANJ_A Chain A, Crystal Structure Of Cdk2 In Complex With N-(9h-purin-6-yl) 
Thiophene-2-carboxamide Processed With The Crystaldirect 
Automated Mounting And Cryo-cooling Technology
 5ANK_A Chain A, Crystal Structure Of Cdk2 In Complex With 2,4,6-trioxo-1- 
Phenyl-hexahydropyrimidine-5-carboxamide Processed With 
The Crystaldirect Automated Mounting And Cryo-cooling Technology
 5ANO_A Chain A, Crystal Structure Of Cdk2 Processed With The Crystaldirect 
Automated Mounting And Cryo-cooling Technology
 5IEV_A Chain A, Crystal Structure Of Bay 1000394 (roniciclib) Bound 
To Cdk2
 5IEX_A Chain A, Crystal Structure Of (r,s)-s-{4-[(5-bromo-4-{[(2r,3r)-2-hydroxy-1- 
Methylpropyl]oxy}- Pyrimidin-2-yl)amino]phenyl}-s- 
Cyclopropylsulfoximide Bound To Cdk2
 5IEY_A Chain A, Crystal Structure Of A Cdk Inhibitor Bound To Cdk2
 5IF1_A Chain A, Crystal Structure Apo Cdk2/cyclin A
 5IF1_C Chain C, Crystal Structure Apo Cdk2/cyclin A
 5JQ5_A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor 
Icec0942
 5JQ8_A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor 
Icec0943
Length=298

 Score = 247 bits (631),  Expect = 5e-81, Method: Compositional matrix adjust.
 Identities = 134/295 (45%), Positives = 189/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  59

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  60   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  112

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  113  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  172

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  173  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287


>2W17_A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, 
Compound (S)-8b
 3IG7_A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor 
Efp With Cdk-2
 3IGG_A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor 
Efq With Cdk-2
 1B38_A Chain A, Human Cyclin-Dependent Kinase 2
 1B39_A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 
160
 1E1V_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
Nu2058
 1E1X_A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 
Nu6027
 1H00_A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino 
Pyrimidine Cdk4 Inhibitor
 1H07_A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino 
Pyrimidine Cdk4 Inhibitor
 1H08_A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino 
Pyrimidine Cdk4 Inhibitor
 2R3R_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 4ACM_A Chain A, Cdk2 In Complex With 3-Amino-6-(4-{[2-(Dimethylamino)ethyl] 
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
 3SW4_A Chain A, Crystal Structure Of The Cdk2 In Complex With Thiazolylpyrimidine 
Inhibitor
 3SW7_A Chain A, Crystal Structure Of The Cdk2 In Complex With Thiazolylpyrimidine 
Inhibitor
 1OIQ_A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent 
Kinase Inhibitors Identified Through Structure-Based 
Hybridisation
 1V1K_A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino 
Pyrimidine Cdk4 Inhibitor
 1URW_A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
 2VV9_A Chain A, Cdk2 In Complex With An Imidazole Piperazine
 2W06_A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl Pyrimidine, 
Compound 5c
 2R3G_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 2R3H_A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With 
Inhibitor
 2R3F_A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With 
Inhibitor
 4EK3_A Chain A, Crystal Structure Of Apo Cdk2
 4EK4_A Chain A, Crystal Structure Of The Cdk2 In Complex With Aminopyrazole 
Inhibitor
 4EK5_A Chain A, Crystal Structure Of The Cdk2 In Complex With Aminopyrazole 
Inhibitor
 4EK6_A Chain A, Crystal Structure Of The Cdk2 In Complex With Aminopyrazole 
Inhibitor
 4EK8_A Chain A, Crystal Structure Of The Cdk2 In Complex With Thiazolylpyrimidine 
Inhibitor
 4FKG_A Chain A, Crystal Structure Of The Cdk2 In Complex With Aminopyrazole 
Inhibitor
 4FKI_A Chain A, Crystal Structure Of The Cdk2 In Complex With Aminopyrazole 
Inhibitor
 4FKJ_A Chain A, Crystal Structure Of The Cdk2 In Complex With Aminopyrazole 
Inhibitor
 4FKL_A Chain A, Crystal Structure Of The Cdk2 In Complex With Thiazolylpyrimidine 
Inhibitor
 4FKO_A Chain A, Crystal Structure Of The Cdk2 In Complex With Thiazolylpyrimidine 
Inhibitor
 4FKP_A Chain A, Crystal Structure Of The Cdk2 In Complex With Oxindole 
Inhibitor
 4FKQ_A Chain A, Crystal Structure Of The Cdk2 In Complex With Oxindole 
Inhibitor
 4FKR_A Chain A, Crystal Structure Of The Cdk2 In Complex With Oxindole 
Inhibitor
 4FKS_A Chain A, Crystal Structure Of The Cdk2 In Complex With Oxindole 
Inhibitor
 4FKT_A Chain A, Crystal Structure Of The Cdk2 In Complex With Oxindole 
Inhibitor
 4FKU_A Chain A, Crystal Structure Of The Cdk2 In Complex With Oxindole 
Inhibitor
 4FKV_A Chain A, Crystal Structure Of The Cdk2 In Complex With Oxindole 
Inhibitor
 4FKW_A Chain A, Crystal Structure Of The Cdk2 In Complex With Oxindole 
Inhibitor
 4BZD_A Chain A, Structure Of Cdk2 In Complex With A Benzimidazopyrimidine
 5A14_A Chain A, Human Cdk2 With Type Ii Inhibitor
Length=299

 Score = 247 bits (631),  Expect = 5e-81, Method: Compositional matrix adjust.
 Identities = 134/295 (45%), Positives = 189/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  60

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  61   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  113

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  114  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  173

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  174  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  233

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  234  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  288


>3PJ8_A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine 
Bioisostere Of Roscovitine.
Length=299

 Score = 247 bits (631),  Expect = 6e-81, Method: Compositional matrix adjust.
 Identities = 134/295 (45%), Positives = 189/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  5    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  60

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  61   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  113

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  114  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  173

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  174  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  233

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  234  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  288


>5UQ1_A Chain A, Crystal Structure Of Human Cdk2-spy1 Complex
 5UQ1_C Chain C, Crystal Structure Of Human Cdk2-spy1 Complex
 5UQ2_A Chain A, Crystal Structure Of Human Cdk2-spy1 Complex
 5UQ3_A Chain A, Crystal Structure Of Human Cdk2-spy1-p27 Ternary Complex
Length=301

 Score = 247 bits (631),  Expect = 7e-81, Method: Compositional matrix adjust.
 Identities = 134/295 (45%), Positives = 189/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  7    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  62

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  63   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  115

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  116  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  175

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  176  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  235

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  236  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  290


>2IW6_A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed 
With A Bisanilinopyrimidine Inhibitor
 2IW6_C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed 
With A Bisanilinopyrimidine Inhibitor
 2IW9_A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed 
With A Bisanilinopyrimidine Inhibitor
 2IW9_C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed 
With A Bisanilinopyrimidine Inhibitor
Length=302

 Score = 247 bits (631),  Expect = 7e-81, Method: Compositional matrix adjust.
 Identities = 134/299 (45%), Positives = 190/299 (64%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  60

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+T++D +   G+P   IK  +
Sbjct  61   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL  112

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  113  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  172

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  173  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  232

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  291


>4ERW_A Chain A, Cdk2 In Complex With Staurosporine
Length=306

 Score = 247 bits (631),  Expect = 8e-81, Method: Compositional matrix adjust.
 Identities = 134/295 (45%), Positives = 189/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  12   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  67

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  68   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  120

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  121  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  180

Query  185  VLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  181  ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  240

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  241  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  295


>3PXF_A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene 
Sulfonate
 3PXQ_A Chain A, Cdk2 In Complex With 3 Molecules Of 8-Anilino-1-Naphthalene 
Sulfonate
 3PXR_A Chain A, Apo Cdk2 Crystallized From Jeffamine
 3PXY_A Chain A, Cdk2 In Complex With Inhibitor Jws648
 3PXZ_A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
 3PY0_A Chain A, Cdk2 In Complex With Inhibitor Su9516
 3PY1_A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
 3QL8_A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
 3QQF_A Chain A, Cdk2 In Complex With Inhibitor L1
 3QQG_A Chain A, Cdk2 In Complex With Inhibitor L2-5
 3QQH_A Chain A, Cdk2 In Complex With Inhibitor L2-2
 3QQJ_A Chain A, Cdk2 In Complex With Inhibitor L2
 3QQL_A Chain A, Cdk2 In Complex With Inhibitor L3
 3QRT_A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
 3QRU_A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
 3QWJ_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
 3QWK_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
 3QX2_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
 3QX4_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
 3QXO_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
 3QZF_A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
 3QZG_A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
 3QZH_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
 3QZI_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
 3R1Q_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
 3R1S_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
 3R1Y_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
 3R28_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
 3R6X_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
 3R71_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
 3R73_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
 3R7E_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
 3R7I_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
 3R7U_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
 3R7V_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
 3R7Y_A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
 3R83_A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
 3R8L_A Chain A, Cdk2 In Complex With Inhibitor L3-4
 3R8M_A Chain A, Cdk2 In Complex With Inhibitor L3-3
 3R8P_A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
 3RAI_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
 3RM6_A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
 3RM7_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
 3ROY_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
 3RPO_A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
 4EZ3_A Chain A, Cdk2 In Complex With Nsc 134199
 4EZ7_A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of 
8-Anilino-1- Naphthalene Sulfonic Acid
 3QQK_A Chain A, Cdk2 In Complex With Inhibitor L4
 3QTQ_A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
 3QTR_A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
 3QTS_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
 3QTU_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
 3QTW_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
 3QTX_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
 3QTZ_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
 3QU0_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
 3QXP_A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
 3R8U_A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
 3R8V_A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
 3R8Z_A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
 3R9D_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
 3R9H_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
 3R9N_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
 3R9O_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
 3RAH_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
 3RAK_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
 3RAL_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
 3RJC_A Chain A, Cdk2 In Complex With Inhibitor L4-12
 3RK5_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
 3RK7_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
 3RK9_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
 3RKB_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
 3RMF_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
 3RNI_A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
 3RPR_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
 3RPV_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
 3RPY_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
 3RZB_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
 3S00_A Chain A, Cdk2 In Complex With Inhibitor L4-14
 3S0O_A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
 3S1H_A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
 3SQQ_A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
 4GCJ_A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length=306

 Score = 247 bits (630),  Expect = 1e-80, Method: Compositional matrix adjust.
 Identities = 134/295 (45%), Positives = 189/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  12   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  67

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  68   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  120

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  121  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  180

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  181  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  240

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  241  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  295


>4EOO_A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 
Complex With Atp
 4EOO_C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 
Complex With Atp
Length=299

 Score = 246 bits (629),  Expect = 1e-80, Method: Compositional matrix adjust.
 Identities = 134/299 (45%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  58

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  59   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  110

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKPEN+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  111  FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  170

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  171  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  230

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  231  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  289


>4EOI_A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin 
A3 Complex With The Inhibitor Ro3306
 4EOI_C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin 
A3 Complex With The Inhibitor Ro3306
Length=299

 Score = 246 bits (629),  Expect = 1e-80, Method: Compositional matrix adjust.
 Identities = 134/299 (45%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  57

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  58   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYL  109

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKPEN+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  110  FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  169

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  170  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  229

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  230  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  288


>4EOP_A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 
Complex With The Inhibitor Ro3306
 4EOP_C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 
Complex With The Inhibitor Ro3306
Length=300

 Score = 246 bits (629),  Expect = 2e-80, Method: Compositional matrix adjust.
 Identities = 134/299 (45%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  59

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  60   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  111

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKPEN+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  112  FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  171

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  172  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  231

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  232  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  290


>1VYW_A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
 1VYW_C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
 2C4G_A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
 2C4G_C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
 2BPM_A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
 2BPM_C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
 2BKZ_A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
 2BKZ_C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
 2WIH_A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
 2WIH_C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
 2WIP_A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1- 
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3- Carboxylic 
Acid
 2WIP_C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1- 
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3- Carboxylic 
Acid
 2WPA_A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles: 
Identification Of Pha-793887, A Potent Cdk Inhibitor Suitable 
For Intravenous Dosing
 2WPA_C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles: 
Identification Of Pha-793887, A Potent Cdk Inhibitor Suitable 
For Intravenous Dosing
 2WXV_A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H) Quinazoline-3-Carboxamide 
Inhibitor
 2WXV_C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H) Quinazoline-3-Carboxamide 
Inhibitor
Length=309

 Score = 246 bits (629),  Expect = 2e-80, Method: Compositional matrix adjust.
 Identities = 134/295 (45%), Positives = 189/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  9    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  64

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  65   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  117

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  118  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  177

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  178  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  237

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  238  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  292


>2JGZ_A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin 
B
Length=289

 Score = 246 bits (627),  Expect = 2e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  57

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  58   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  109

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  110  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  169

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  170  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  229

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  230  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  288


>1QMZ_A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 1QMZ_C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 1GY3_A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE 
SUBSTRATE
 1GY3_C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE 
SUBSTRATE
 1P5E_A Chain A, The Structure Of Phospho-cdk2/cyclin A In Complex With 
The Inhibitor 4,5,6,7-tetrabromobenzotriazole (tbs)
 1P5E_C Chain C, The Structure Of Phospho-cdk2/cyclin A In Complex With 
The Inhibitor 4,5,6,7-tetrabromobenzotriazole (tbs)
 2CCH_A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With 
A Substrate Peptide Derived From Cdc Modified With A Gamma- 
Linked Atp Analogue
 2CCH_C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With 
A Substrate Peptide Derived From Cdc Modified With A Gamma- 
Linked Atp Analogue
 2CCI_A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex 
With A Peptide Containing Both The Substrate And Recruitment 
Sites Of Cdc6
 2CCI_C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex 
With A Peptide Containing Both The Substrate And Recruitment 
Sites Of Cdc6
 2G9X_A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN 
COMPLEX WITH THE Inhibitor Nu6271
 2G9X_C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN 
COMPLEX WITH THE Inhibitor Nu6271
 3DDP_A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX 
With The Inhibitor Cr8
 3DDP_C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX 
With The Inhibitor Cr8
 3DDQ_A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX 
With The Inhibitor Roscovitine
 3DDQ_C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX 
With The Inhibitor Roscovitine
 3DOG_A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN 
Complex With The Inhibitor N-&-N1
 3DOG_C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN 
Complex With The Inhibitor N-&-N1
 5L2W_A Chain A, The X-ray Co-crystal Structure Of Human Cdk2/cycline 
And Dinaciclib.
 5LMK_A Chain A, Structure Of Phopsho-cdk2-cyclin A In Complex With An 
Atp-competitive Inhibitor
Length=299

 Score = 245 bits (626),  Expect = 3e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  57

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  58   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  109

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  110  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  169

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  170  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  229

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  230  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  288


>1E9H_A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex 
With The Inhibitor Indirubin-5-Sulphonate Bound
 1E9H_C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex 
With The Inhibitor Indirubin-5-Sulphonate Bound
 1PKD_A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho- 
Cdk2CYCLIN A
 1PKD_C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho- 
Cdk2CYCLIN A
 5LMK_C Chain C, Structure Of Phopsho-cdk2-cyclin A In Complex With An 
Atp-competitive Inhibitor
Length=297

 Score = 245 bits (626),  Expect = 3e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  57

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  58   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  109

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  110  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  169

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  170  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  229

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  230  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  288


>3BHT_A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX 
WITH THE Inhibitor Meriolin 3
 3BHT_C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX 
WITH THE Inhibitor Meriolin 3
 3BHU_A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX 
WITH THE Inhibitor Meriolin 5
 3BHU_C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX 
WITH THE Inhibitor Meriolin 5
 3BHV_A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX 
With The Inhibitor Variolin B
 3BHV_C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX 
With The Inhibitor Variolin B
 3MY5_A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
 3MY5_C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
 3TNW_A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
 3TNW_C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
 4BCO_A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
 4BCO_C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
 4BCK_A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
 4BCK_C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
 4BCN_A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
 4BCN_C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
 4BCP_A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
 4BCP_C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
Length=300

 Score = 245 bits (626),  Expect = 3e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  58

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  59   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  110

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  111  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  170

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  171  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  230

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  231  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  289


>1W98_A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
 4EOR_A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex 
With The Inhibitor Nu6102
 4EOR_C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex 
With The Inhibitor Nu6102
Length=298

 Score = 245 bits (626),  Expect = 3e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  57

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  58   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  109

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  110  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  169

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  170  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  229

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  230  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  288


>4I3Z_A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM 
IONS
 4I3Z_C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM 
IONS
Length=296

 Score = 245 bits (626),  Expect = 4e-80, Method: Compositional matrix adjust.
 Identities = 133/295 (45%), Positives = 188/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  59

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  60   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  112

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWYRAPE
Sbjct  113  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE  172

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  173  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287


>1H01_A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino 
Pyrimidine Cdk4 Inhibitor
 4RJ3_A Chain A, Cdk2 With Egfr Inhibitor Compound 8
Length=298

 Score = 245 bits (626),  Expect = 4e-80, Method: Compositional matrix adjust.
 Identities = 133/295 (45%), Positives = 188/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VAL  +R+     G   +P + +RE++LL+ L  
Sbjct  4    FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEG---VPSTAIREISLLKELN-  59

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  60   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  112

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  113  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  172

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  173  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287


>1OIR_A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent 
Kinase Inhibitors Identified Through Structure-Based 
Hybridisation
Length=299

 Score = 245 bits (626),  Expect = 4e-80, Method: Compositional matrix adjust.
 Identities = 133/295 (45%), Positives = 188/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VAL  +R+     G   +P + +RE++LL+ L  
Sbjct  5    FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEG---VPSTAIREISLLKELN-  60

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  61   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  113

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +   T  VVTLWYRAPE
Sbjct  114  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  173

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  174  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  233

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  234  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  288


>1JST_A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin 
A
 1JST_C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin 
A
 1JSU_A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
 1FQ1_B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap) 
In Complex With Phospho-Cdk2
 2C6T_A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The 
Triazolopyrimidine Inhibitor
 2C6T_C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The 
Triazolopyrimidine Inhibitor
 2UZB_A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone 
Inhibitor
 2UZB_C Chain C, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone 
Inhibitor
 2UZD_A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone 
Inhibitor
 2UZD_C Chain C, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone 
Inhibitor
 2UZE_A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone 
Inhibitor
 2UZE_C Chain C, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone 
Inhibitor
 2UZL_A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone 
Inhibitor
 2UZL_C Chain C, Crystal Structure Of Human Cdk2 Complexed With A Thiazolidinone 
Inhibitor
 4II5_A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium 
Ion
 4II5_C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium 
Ion
Length=298

 Score = 245 bits (626),  Expect = 4e-80, Method: Compositional matrix adjust.
 Identities = 133/295 (45%), Positives = 188/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  4    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  59

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  60   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  112

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWYRAPE
Sbjct  113  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE  172

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  173  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287


>3QHR_A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 3QHR_C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 3QHW_A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 3QHW_C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length=298

 Score = 245 bits (626),  Expect = 4e-80, Method: Compositional matrix adjust.
 Identities = 133/295 (45%), Positives = 188/295 (64%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  6    FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  61

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  62   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  114

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWYRAPE
Sbjct  115  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE  174

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  175  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  234

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  235  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  289


>4BCQ_A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
 4BCQ_C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
 4BCM_A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
 4BCM_C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- 
Heteroaryl-pyrimidine Inhibitor
Length=301

 Score = 245 bits (626),  Expect = 4e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  59

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  60   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  111

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  112  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  171

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  172  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  231

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  232  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  290


>4EOQ_A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex 
With Atp
 4EOQ_C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex 
With Atp
Length=301

 Score = 245 bits (626),  Expect = 4e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  60

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  61   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  112

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  113  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  172

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  173  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  232

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  291


>4EOS_A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex 
With The Inhibitor Ro3306
 4EOS_C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex 
With The Inhibitor Ro3306
Length=300

 Score = 245 bits (626),  Expect = 4e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  59

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  60   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  111

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  112  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  171

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  172  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  231

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  232  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  290


>1OGU_A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed 
With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine 
Inhibitor
 1OGU_C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed 
With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine 
Inhibitor
 1OI9_A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 1OI9_C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 1OIU_A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 1OIU_C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 1OIY_A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 1OIY_C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 4CFN_A Chain A, Structure-based Design Of C8-substituted O6-cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
 4CFN_C Chain C, Structure-based Design Of C8-substituted O6-cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
Length=302

 Score = 245 bits (626),  Expect = 4e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  60

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  61   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  112

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  113  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  172

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  173  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  232

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  291


>1H1P_A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With The Inhibitor Nu2058
 1H1P_C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With The Inhibitor Nu2058
 1H1Q_A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With The Inhibitor Nu6094
 1H1Q_C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With The Inhibitor Nu6094
 1H1R_A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With The Inhibitor Nu6086
 1H1R_C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With The Inhibitor Nu6086
 1H1S_A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With The Inhibitor Nu6102
 1H1S_C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED 
With The Inhibitor Nu6102
 1H24_A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT 
Peptide From E2f
 1H24_C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT 
Peptide From E2f
 1H25_A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment 
Peptide From Retinoblastoma-Associated Protein
 1H25_C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment 
Peptide From Retinoblastoma-Associated Protein
 1H26_A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment 
Peptide From P53
 1H26_C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment 
Peptide From P53
 1H27_A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment 
Peptide From P27
 1H27_C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment 
Peptide From P27
 1H28_A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment 
Peptide From P107
 1H28_C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment 
Peptide From P107
 2WMA_A Chain A, Structural And Thermodynamic Consequences Of Cyclization 
Of Peptide Ligands For The Recruitment Site Of Cyclin A
 2WMA_C Chain C, Structural And Thermodynamic Consequences Of Cyclization 
Of Peptide Ligands For The Recruitment Site Of Cyclin A
 2WMB_A Chain A, Structural And Thermodynamic Consequences Of Cyclization 
Of Peptide Ligands For The Recruitment Site Of Cyclin A
 2WMB_C Chain C, Structural And Thermodynamic Consequences Of Cyclization 
Of Peptide Ligands For The Recruitment Site Of Cyclin A
 4CFW_A Chain A, Structure-based Design Of C8-substituted O6- Cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
 4CFW_C Chain C, Structure-based Design Of C8-substituted O6- Cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
 4CFM_A Chain A, Structure-based Design Of C8-substituted O6- Cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
 4CFM_C Chain C, Structure-based Design Of C8-substituted O6- Cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
 4CFX_A Chain A, Structure-based Design Of C8-substituted O6-cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
 4CFX_C Chain C, Structure-based Design Of C8-substituted O6-cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
 5CYI_A Chain A, Cdk2/cyclin A Covalent Complex With 6-(cyclohexylmethoxy)-n-(4- 
(vinylsulfonyl)phenyl)-9h-purin-2-amine (nu6300)
 5CYI_C Chain C, Cdk2/cyclin A Covalent Complex With 6-(cyclohexylmethoxy)-n-(4- 
(vinylsulfonyl)phenyl)-9h-purin-2-amine (nu6300)
 5LQE_A Chain A, Cdk2/cyclin A In Complex With Compound 73
 5LQE_C Chain C, Cdk2/cyclin A In Complex With Compound 73
 5NEV_A Chain A, Cdk2/cyclin A In Complex With Compound 73
 5NEV_C Chain C, Cdk2/cyclin A In Complex With Compound 73
Length=303

 Score = 245 bits (626),  Expect = 5e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  5    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  61

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  62   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  113

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  114  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  173

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  174  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  233

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  234  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  292


>4EON_A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human 
Cyclin A3 Complex With The Inhibitor Ro3306
 4EON_C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human 
Cyclin A3 Complex With The Inhibitor Ro3306
Length=300

 Score = 245 bits (625),  Expect = 5e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 188/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  58

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE +  DL+ ++D +   G+P   IK  +
Sbjct  59   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL  110

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKPEN+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  111  FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  170

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  171  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  230

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  231  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  289


>4CFU_A Chain A, Structure-based Design Of C8-substituted O6- Cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
 4CFU_C Chain C, Structure-based Design Of C8-substituted O6- Cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
 4CFV_A Chain A, Structure-based Design Of C8-substituted O6- Cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
 4CFV_C Chain C, Structure-based Design Of C8-substituted O6- Cyclohexylmethoxyguanine 
Cdk1 And 2 Inhibitors.
Length=303

 Score = 245 bits (625),  Expect = 5e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 189/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  5    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  61

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  +
Sbjct  62   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL  113

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  114  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  173

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  174  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  233

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  234  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  292


>4EOM_A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human 
Cyclin A3 Complex With Atp
 4EOM_C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human 
Cyclin A3 Complex With Atp
Length=301

 Score = 244 bits (624),  Expect = 7e-80, Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 188/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  60

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE +  DL+ ++D +   G+P   IK  +
Sbjct  61   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL  112

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKPEN+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  113  FQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  172

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  173  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  232

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  291


>4EOK_A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human 
Cyclin A3 Complex With The Inhibitor Nu6102
 4EOK_C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human 
Cyclin A3 Complex With The Inhibitor Nu6102
 4EOL_A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human 
Cyclin A3 Complex With The Inhibitor Ro3306
 4EOL_C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human 
Cyclin A3 Complex With The Inhibitor Ro3306
Length=300

 Score = 243 bits (621),  Expect = 2e-79, Method: Compositional matrix adjust.
 Identities = 132/299 (44%), Positives = 188/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  59

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE +  DL+ ++D +   G+P   IK  +
Sbjct  60   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL  111

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  112  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  171

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  172  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  231

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  232  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  290


>4EOJ_A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human 
Cyclin A3 Complex With Atp
 4EOJ_C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human 
Cyclin A3 Complex With Atp
Length=302

 Score = 243 bits (620),  Expect = 3e-79, Method: Compositional matrix adjust.
 Identities = 132/299 (44%), Positives = 188/299 (63%), Gaps = 15/299 (5%)

Query  2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR  61
            +   ++ V +IG G YG VYKAR+  +G  VALK +R+     G   +P + +RE++LL+
Sbjct  4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLK  60

Query  62   RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM  121
             L    HPN+V+L+DV  T     E K+ LVFE +  DL+ ++D +   G+P   IK  +
Sbjct  61   ELN---HPNIVKLLDVIHT-----ENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL  112

Query  122  RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWY  180
             Q L+GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWY
Sbjct  113  FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY  172

Query  181  RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  239
            RAPE+LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP
Sbjct  173  RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP  232

Query  240  RDVSLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
               S+P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  291


>2CJM_A Chain A, Mechanism Of Cdk Inhibition By Active Site Phosphorylation: 
Cdk2 Y15p T160p In Complex With Cyclin A Structure
 2CJM_C Chain C, Mechanism Of Cdk Inhibition By Active Site Phosphorylation: 
Cdk2 Y15p T160p In Complex With Cyclin A Structure
Length=298

 Score = 242 bits (618),  Expect = 6e-79, Method: Compositional matrix adjust.
 Identities = 132/295 (45%), Positives = 187/295 (63%), Gaps = 15/295 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            ++ V +IG G  G VYKAR+  +G  VALK +R+     G   +P + +RE++LL+ L  
Sbjct  4    FQKVEKIGEGTXGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELN-  59

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  125
              HPN+V+L+DV  T     E K+ LVFE + QDL+ ++D +   G+P   IK  + Q L
Sbjct  60   --HPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL  112

Query  126  RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE  184
            +GL F H++ ++HRDLKP+N+L+ + G +KLADFGLAR +   +      VVTLWYRAPE
Sbjct  113  QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE  172

Query  185  VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS  243
            +LL    Y+T VD+WS+GCIFAEM  R+ LF G+SE DQL +IF  +G P E  WP   S
Sbjct  173  ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232

Query  244  LP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            +P  + +FP    +    VVP ++E G  LL +ML ++P+KRISA  AL H +  
Sbjct  233  MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ  287


>4YC6_A Chain A, Cdk1/cks1
 4YC6_C Chain C, Cdk1/cks1
 4YC6_E Chain E, Cdk1/cks1
 4YC6_G Chain G, Cdk1/cks1
Length=297

 Score = 236 bits (602),  Expect = 1e-76, Method: Compositional matrix adjust.
 Identities = 128/296 (43%), Positives = 184/296 (62%), Gaps = 16/296 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            Y  + +IG G YG VYK R   +G  VA+K +R+ +   G   +P + +RE++LL+ L  
Sbjct  4    YTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEG---VPSTAIREISLLKELR-  59

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPP-PGLPAETIKDLMRQF  124
              HPN+V L DV       ++ ++ L+FE +  DL+ YLD  PP   + +  +K  + Q 
Sbjct  60   --HPNIVSLQDVLM-----QDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQI  112

Query  125  LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVVTLWYRAP  183
            L+G+ F H+  ++HRDLKP+N+L+   GT+KLADFGLAR +   + + T  VVTLWYR+P
Sbjct  113  LQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSP  172

Query  184  EVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  242
            EVLL S  Y+TPVD+WS+G IFAE+  +KPLF G+SE DQL +IF  +G P  + WP   
Sbjct  173  EVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVE  232

Query  243  SLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            SL   +  FP   P  + S V  ++E+G  LL +ML ++P KRIS   AL H Y +
Sbjct  233  SLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFN  288


>4Y72_A Chain A, Human Cdk1/cyclinb1/cks2 With Inhibitor
 5HQ0_A Chain A, Ternary Complex Of Human Proteins Cdk1, Cyclin B And 
Cks2, Bound To An Inhibitor
 5LQF_A Chain A, Cdk1/cyclinb1/cks2 In Complex With Nu6102
 5LQF_D Chain D, Cdk1/cyclinb1/cks2 In Complex With Nu6102
 4YC3_A Chain A, Cdk1/cyclinb1/cks2 Apo
Length=302

 Score = 236 bits (602),  Expect = 2e-76, Method: Compositional matrix adjust.
 Identities = 128/296 (43%), Positives = 184/296 (62%), Gaps = 16/296 (5%)

Query  6    YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA  65
            Y  + +IG G YG VYK R   +G  VA+K +R+ +   G   +P + +RE++LL+ L  
Sbjct  9    YTKIEKIGEGTYGVVYKGRHKTTGQVVAMKKIRLESEEEG---VPSTAIREISLLKELR-  64

Query  66   FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPP-PGLPAETIKDLMRQF  124
              HPN+V L DV       ++ ++ L+FE +  DL+ YLD  PP   + +  +K  + Q 
Sbjct  65   --HPNIVSLQDVLM-----QDSRLYLIFEFLSMDLKKYLDSIPPGQYMDSSLVKSYLYQI  117

Query  125  LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVVTLWYRAP  183
            L+G+ F H+  ++HRDLKP+N+L+   GT+KLADFGLAR +   + + T  VVTLWYR+P
Sbjct  118  LQGIVFCHSRRVLHRDLKPQNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSP  177

Query  184  EVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  242
            EVLL S  Y+TPVD+WS+G IFAE+  +KPLF G+SE DQL +IF  +G P  + WP   
Sbjct  178  EVLLGSARYSTPVDIWSIGTIFAELATKKPLFHGDSEIDQLFRIFRALGTPNNEVWPEVE  237

Query  243  SLP--RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  296
            SL   +  FP   P  + S V  ++E+G  LL +ML ++P KRIS   AL H Y +
Sbjct  238  SLQDYKNTFPKWKPGSLASHVKNLDENGLDLLSKMLIYDPAKRISGKMALNHPYFN  293


>1V0B_A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
 1V0B_B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length=288

 Score = 234 bits (598),  Expect = 4e-76, Method: Compositional matrix adjust.
 Identities = 128/299 (43%), Positives = 188/299 (63%), Gaps = 17/299 (6%)

Query  4    SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL  63
             +Y  + +IG G YG VYKA++ + G   ALK +R+     G   +P +T+RE+++L+ L
Sbjct  2    EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEG---IPSTTIREISILKEL  57

Query  64   EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ  123
            +   H N+V+L DV  T +     ++ LVFEH+DQDL+  LD     GL + T K  + Q
Sbjct  58   K---HSNIVKLYDVIHTKK-----RLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQ  108

Query  124  FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRA  182
             L G+ + H   ++HRDLKP+N+L+   G +K+ADFGLAR +   +   T  VVTLWYRA
Sbjct  109  LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRA  168

Query  183  PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  241
            P+VL+ S  Y+T +D+WSVGCIFAEM    PLF G SEADQL +IF ++G P   +WP  
Sbjct  169  PDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228

Query  242  VSLPRG--AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  298
              LP+    F    P P +S +  ++ESG  LL +ML  +P++RI+A +AL+H+Y  ++
Sbjct  229  TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287


  Database: PDB protein database
    Posted date:  Aug 6, 2017  2:16 PM
  Number of letters in database: 23,299,537
  Number of sequences in database:  92,826

Lambda      K        H
   0.321    0.140    0.429 
Gapped
Lambda      K        H
   0.267   0.0410    0.140 
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 92826
Number of Hits to DB: 3781636
Number of extensions: 166018
Number of successful extensions: 2007
Number of sequences better than 100: 633
Number of HSP's better than 100 without gapping: 0
Number of HSP's gapped: 1017
Number of HSP's successfully gapped: 676
Length of query: 303
Length of database: 23299537
Length adjustment: 102
Effective length of query: 201
Effective length of database: 13831285
Effective search space: 2780088285
Effective search space used: 2780088285
T: 11
A: 40
X1: 16 (7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (20.4 bits)
S2: 53 (25.0 bits)
ka-blk-alpha gapped: 1.9
ka-blk-alpha ungapped: 0.7916
ka-blk-alpha_v gapped: 42.6028
ka-blk-alpha_v ungapped: 4.96466
ka-blk-sigma gapped: 43.6362




P11802.fasta